ABSTRACT. We have previously demonstrated that systemic atrial natriuretic factor (ANF) infusion induced a renal vasoconstrictor response in fetal and newborn sheep. The present study was designed to test the hypothesis that the fetal and neonatal renal vasculatures do, in fact, vasodilate in response to ANF but that this effect is negated by vasoconstrictor compensatory mechanisms when ANF is infused systemically. To test this hypothesis, the renal hemodynamic response to intrarenal infusion of ANF was studied in chronically instrumented fetal (125-135 d of gestation; term 145 d) and newborn (8-15 d) sheep. Intrarenal infusion of ANF (0.125 to 4.0 pg/kg of body wt in fetuses and 0.25 to 8.0 pg/kg in newborns) had no significant effect on mean arterial blood pressure and heart rate. (5, 7) suggest that the cardiovascular, renal hemodynamic, and possibly renal function responses to continuous intravenous infusion of ANF change during maturation. It has been found that the natriuresis and chloruresis produced by systemic infusion of ANF is of greater magnitude in adult than in fetal sheep (3). Systemic ANF infusion decreases arterial blood pressure and increases heart rate in newborn and adult sheep (3). In fetal sheep, ANF produces either a decrease (7) or no change (3, 5) in arterial blood pressure associated with either a rise (5, 7) or no change (3) in heart rate. It has also been demonstrated that systemic ANF infusion decreases RBF and increases RVR in fetal and newborn animals but decreases RVR in adult sheep (3).
ABSTRACT. We have previously demonstrated that systemic atrial natriuretic factor (ANF) infusion induced a renal vasoconstrictor response in fetal and newborn sheep. The present study was designed to test the hypothesis that the fetal and neonatal renal vasculatures do, in fact, vasodilate in response to ANF but that this effect is negated by vasoconstrictor compensatory mechanisms when ANF is infused systemically. To test this hypothesis, the renal hemodynamic response to intrarenal infusion of ANF was studied in chronically instrumented fetal (125-135 d of gestation; term 145 d) and newborn (8-15 d) sheep. Intrarenal infusion of ANF (0.125 to 4.0 pg/kg of body wt in fetuses and 0.25 to 8.0 pg/kg in newborns) had no significant effect on mean arterial blood pressure and heart rate. However, ANF produced a concentration-dependent increase in renal blood flow velocity (F = 40.9, p < 0.001) and a decrease in renal vascular resistance (F = 38.3, p < 0.001) in both groups. The magnitude of changes in renal blood flow velocity and renal vascular resistance expressed as percentage of changes (%A) from control values, were similar (p > 0.05) in both fetal and newborn sheep during intrarenal infusion of ANF. These results demonstrate that ANF exerts direct vasodilator action on the fetal and neonatal renal vasculature and that the renal vasoconstriction previously observed during systemic infusion of ANF was probably secondary to activation of compensatory mechanisms. (Pediatr Res 25:291-294, 1989 Abbreviations ANF, atrial natriuretic factor RBF, renal blood flow RBFV, renal blood flow velocity RVR, renal vascular resistance %A, percentage of change D5W, 5% dextrose in water Recent studies by our group (3) as well as by others (5, 7) suggest that the cardiovascular, renal hemodynamic, and possibly renal function responses to continuous intravenous infusion of ANF change during maturation. It has been found that the natriuresis and chloruresis produced by systemic infusion of ANF is of greater magnitude in adult than in fetal sheep (3) . Systemic ANF infusion decreases arterial blood pressure and increases heart rate in newborn and adult sheep (3) . In fetal sheep, ANF produces either a decrease (7) or no change (3, 5) in arterial blood pressure associated with either a rise (5, 7) or no change (3) in heart rate. It has also been demonstrated that systemic ANF infusion decreases RBF and increases RVR in fetal and newborn animals but decreases RVR in adult sheep (3) .
No studies have demonstrated if this renal vasoconstrictor response to systemic ANF infusion is particular to the renal vasculature of developing animals or is secondary to compensatory mechanisms. The present study was designed to evaluate the renal hemodynamic response to direct intrarenal infusion of ANF in conscious and chronically instrumented fetal and newborn sheep and to test the hypothesis that ANF does relax the renal vasculature during renal maturation.
MATERIALS A N D METHODS
Animal preparation and surgical procedures. Fetuses of eight pregnant sheep of Dorset and Suffolk mixed breeding (3.27 f 0.1 1 kg) were studied at 125-135 d of gestation (term being 145 d). Gestational ages were based on the induced ovulation technique as previously described (8) .
Ewes were fasted for 24 h before surgery. General anesthesia of the ewe and fetal surgery were performed as previously described (9) . Briefly, the ewe was anesthetized with a mixture of 1% halothane, 33% oxygen and 66% nitrous oxide. The uterus was opened and polyethylene catheters (outer diameter, 1.27 mm; inner diameter, 0.86 mm) were inserted in both femoral veins and arteries. A catheter was also secured in the amniotic cavity for intrauterine pressure recording. The left kidney of the fetus was exposed through a left flank incision. A Doppler flow probe was secured around the renal artery with care being taken It has been demonstrated that ANF can be synthesized, stored to not interfere with renal innervation. Thereafter, a nonobstrucand secreted by the fetal mammalian heart (1, 2). Studies in tive renal artery catheter was implanted using the method desheep (3-9, rats ( I ) , and humans (6) have shown that ANF is scribed by Herd and Barger (10) and previously used by Nakapresent in fetal blood during the last part of gestation. After suturing all fetal incisions, the fetal membranes, the uterine cavity and the were 'lased in Physiologic studies. Before each study, newborn and fetal sheep were allowed 3 and 6 d, respectively, to recover from surgery. At the time of the study, the pregnant ewe was transferred to a small cart, permitting it to stand. Each lamb was supported upright in a harness.
A 60-min equilibration period was allowed to permit the animal to adapt to the laboratory environment and to ensure stability of the preparation before starting the experiment. Arterial blood was collected from the femoral artery catheter at the beginning and end of each experiment to determine arterial pH and blood gases (Pc02, Po,). During the study, pregnant ewes were allowed free access to water, and newborn lambs received an intravenous infusion of D5W and 0.2% sodium chloride given at a rate of 100 mL . kg body wt-I . 24 h-I. Furthermore, D5W was infused continuously at a rate of 0.1 mL/min into the renal artery of fetal sheep and newborn lambs.
Synthetic a-human atriopeptin (ANF) (Peninsula Laboratories, Belmont, CA) was diluted in D5W and infused directly into the renal artery in 2-fold increments ranging from 0.125 to 4 pg/ kg of body wt in fetuses and 0.25 to 8 pg/kg in newborn lambs. Each dose was infused directly into the renal artery as a 0.3-mL infusion over 30 s using a Harvard pump. In addition, D5W was infused as a vehicle control. Doses of ANF and D5W were administered in a random sequence; each dose was given twice, and the two observations were averaged for further analysis. There was an interval of at least 5 min between each dose to allow RBFV, as determined by the Doppler flowmeter, to return to baseline. Usually RBFV was back to baseline 3 min after ANF administration.
During each experiment, arterial and amniotic pressures were recorded continuously using Statham P23Db pressure transducers (Statham Instruments, Schiller Park, IL). Fetal arterial pressure was corrected relative to concomitant amniotic pressure. Heart rate in fetal and newborn sheep was monitored with a cardiotachometer triggered from the arterial pressure pulse wave.
Changes in RBFV to the left kidney were monitored continuously using an ultrasonic pulsed Doppler flowmeter, modified from the original design of Hartley and Cole (12), and constructed by the University of Iowa Bioengineering Resource Facility (13) . The validity of the pulsed Doppler flowmeter for use in determining %A in RBFV in the present experimental model has previously been demonstrated (1 I). All hemodynamis data were continuously recorded on a Beckman R-6 1 1 recorder (Beckman Instruments, Inc., Palo Alto, CA) and simultaneously with an online computer (IBM-XT, IBM Instruments, Inc., Danbury, CT) using LABTECH NOTEBOOK (Laboratory Technologies Corporation, Wilmington, MA) and Lotus 1-2-3 (Lotus Development Corporation, Cambridge, MA) softwares. The correlation between manually derived and computer analyzed % A in RBFV in 13 l cases ranging from -100% to + 107% was described by the equation: %A in RBF calculated manually from graph paper = 3.6 + (%A in RBF derived by computer calculation x 1.03); r = 0.96, p < 0.000 1.
To determine estimated ANF concentration in renal blood, baseline RBF in mL/min was measured using the microsphere technique. Approximately 4.0 x lo6 radioactive microspheres (15 + 3 pm diameter) labeled with either 14'Ce, 4 6 S~, '%r, or 95Nb (3M CO., St. Paul, MN) were infused over a 30-s period into the fetal femoral vein catheter and then immediately flushed with 3 mL of 0.9% saline solution (14, 15) . In newborn lambs, radioactive microspheres were infused into the left ventricular catheter. Blood for a lower body independent reference sample was collected from the femoral artery during a period of 3 min beginning 20 s before the injection of microsphere at a withdrawal rate of 1.94 mL/min using a Harvard infusion-withdrawal pump. At the end of the experiment, the animals were killed with a lethal dose of pentobarbital sodium (Somlethal, MidTech., Inc., Elwood, KS). Animals were weighed, and the kidneys were removed for radioactivity determination.
To compare dose responses between fetal sheep and newborn lambs, estimated concentrations of ANF in renal blood were determined as previously described (1 I). The molar amount of ANF given was calculated by multiplying the ANF dose in pg/ kg by the wt of the animals and dividing by ANF mol wt (3080.95). This value was then divided by RBF (mL/min) to provide an approximation of molar concentration of ANF in renal blood.
ANALYTICAL PROCEDURES
Arterial blood for pH Pco,, and PO, was collected anaerobically in heparinized syringes, and measurements were immediately determined with the appropriate pH, Pco, and Po, electrodes at 39°C using an IL-1303 pH/blood gas analyzer (Instrument Laboratory System, Houston, TX).
y emissions generated from the microspheres were measured in the left kidney and reference femoral arterial blood samples using a Beckman 300 y spectrometer. Energy window ranges were set between 74-102 keV for 14'Ce, 210-275 keV for "Sr, 310-410 keV for 95Nb, and 420-580 keV for 4 6 S~. Handling of the kidney before counting and isotope separation were as previously described (I 4, 15) .
Computations and data analysis. RBF, using the microsphere technique, was determined according to the following formula: RBF (mL/min) = total kidney counts x reference flow from the femoral artery (mL/min)/total femoral blood counts.
%A RBFV and %A RVR by use of the Doppler flow probe were calculated using the following formulas:
where Eds is the maximum Doppler shift in kHz during intrarenal ANF infusion and Bds is the baseline Doppler shift in kHz; RVR is the renal vascular resistance expressed arbitrarily in mm Hg/ kHz; PP is the renal perfusion pressure estimated to be equal to the mean aortic pressure (mm Hg); DS is the Doppler shift (kHz); and RVR, and RVRb are the RVR during the experimental and baseline periods, respectively.
Comparisons of dose-response curves between fetal and newborn sheep were performed by 2-way ANOVA for repeated measures with Duncan's multiple range test (1 6). Comparisons between control and each concentration of ANF for each age group were made by use of randomized block ANOVA and Dunnett's multiple comparison procedure. Paired t tests were used to compare baseline arterial blood values at the beginning and at the end of the experiment. Unpaired t tests were used to compare baseline values between fetal and newborn sheep. The term "significant" is used throughout to describe changes with a total p value of <0.05 in a 2-sided significance limit. Values are expressed as means + SEM.
RESULTS
Baseline arterial pH, Pco, and Po, and hematocrit values are presented in Table 1 . No changes were observed in these values ONTOGENY O F RBF RESPONSE TO ANF IN SHEEP 293 after intrarenal infusion of ANF. Baseline RBF values measured by the microsphere technique and expressed in mL/min or corrected for kidney wt were lower in fetuses than in newborn lambs ( p < 0.05) ( Table 1) . RVR expressed in mm Hg/ml/min of renal blood flow was significantly higher in fetal sheep than in newborn lambs ( p < 0.05) ( Table 1) .
Effect of intrarenal ANF infusion on arterial blood pressure, heart rate, and renal hemodynamics. Intrarenal infusion of ANF had no significant effect on mean arterial blood pressure and heart rate values in fetal and newborn sheep (Fig. I) .
Intrarenal infusion of ANF produced dose-dependent increases in mean RBFV in fetal and newborn sheep (F = 40.9, p < 0.00 1) (Fig. 2) . Each dose of ANF produced a renal vasodilation that was significantly greater than during infusion of D5W (control). Renal ANF Concentration (M) The renal vasodilatory effect of ANF was similar in both fetal and newborn sheep (F = 0.58, p = 0.45), and no difference at any concentration was observed between both groups of animals. Parallel to the changes in RBFV, intrarenal ANF infusion decreased RVR in a dose-dependent fashion ( F = 38.3, p < 0.001) (Fig. 2) . The decrease in RVR was similar in both fetal and newborn sheep (F = 1.00, p = 0.33).
DISCUSSION
The present study demonstrates that intrarenal infusion of ANF produces renal vasodilation and decreases renal vascular resistance in a dose-dependent fashion in fetal and newborn sheep. These results differ from a previous study (3) in fetal and newborn sheep where it was shown that systemic intravenous infusion of ANF was associated with a decrease in RBFV and a rise in RVR.
Differences between these two studies are intriguing. However, the present results suggest that ANF does not exert a direct vasoconstrictor action on the fetal and neonatal renal vasculature and that the site of administration of the peptide as well as the duration of the infusion play an important role in the renal hemodynamic response to ANF, as previously suggested in adults (17) ; systemic infusion of the peptide produces a renal vasoconstriction (3), whereas intrarenal bolus infusion produces renal vasodilation. One may speculate that systemic infusion of ANF increases sympathetic tone, which opposes the renal vasodilatory action of ANF (18, 19) , whereas ANF infused intrarenally is cleared rapidly by the kidney (20) and has little or no effect on sympathetic vasoconstrictor tone. In support of this hypothesis Lappe et al. (1 8) have demonstrated that surgical denervation or chemical sympathectomy abolishes the renal vasoconstrictor response associated with systemic ANF infusion in spontaneously hypertensive rats. Furthermore, it has been demonstrated that norepinephrine can also inhibit the vasodilatory influence of ANF (21) . Other factors, such as a decrease in cardiac output (22, 23) , activation of the renin-angiotensin system (24) , and redistribution of blood flow away from the renal circulation (25) may have also contributed to the decrease in total renal blood flow observed during systemic infusion of ANF in previous studies (3) .
Finally, as the estimated concentration of ANF in renal blood (5.75 k 0.65 x M to 2.19 f 0.17 x lo-' M) that produces renal vasodilation during intrarenal infusion of ANF is higher than the highest plasma ANF concentration (0.5 x 10-9M) achieved during systemic ANF infusion (3), one may suggest that ANF has no direct renal vasoconstrictor effect. It is also shown that the lowest estimated renal blood concentration of ANF (5.75 + 0.65 x M) producing renal vasodilation in the present in vivo study is close to the in vitro ANF concentration (1.1 x M) needed for threshold stimulation of cGMP in vascular smooth muscle (26) .
The present study also demonstrates that the magnitude of the renal vasodilatory response to intrarenal infusion of ANF (expressed as % A from baseline) is similar in fetal and newborn sheep. In that regard, these results differ from previous studies (27) (28) (29) demonstrating that the renal vasodilatory response to Padrenoceptor stimulation is greater in fetal sheep than in newborn lambs. A recent study (30) using forskolin, a drug known to activate adenylate cyclase directly (3 I), has suggested that the greater P-adrenoceptor-mediated renal vasodilation in fetal sheep may be at the receptor-hormone level. Thus, the present results suggest that the cGMP-dependent renal vasodilatory mechanism (stimulated by ANF) is already mature by the end of gestation, whereas the ability of the renal vasculature to respond to Padrenoceptor stimulation, a CAMP-dependent mechanism, is higher in fetuses than postnatally (30) .
In summary, the present study demonstrates that ANF exerts direct vasodilator action on the fetal and neonatal renal vasculature and suggests that the decrease in renal blood flow previously observed during systemic infusion of ANF (3) was probably secondary to changes in systemic hemodynamics (22, 25) and activation of compensatory mechanisms (18, 19) . Finally, it is shown that the renal vasodilatory response to intrarenal ANF infusion is similar in fetal and newborn sheep. The role of ANF in controlling renal hemodynamics and function during the transition from fetal to newborn life remains to be investigated.
